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ABSTRACT
Introduction Prehabilitation in colorectal surgery is evolving 
and may minimise postoperative morbidity and mortality. 
With many different healthcare professionals contributing 
to the prehabilitation literature, there is significant variation 
in reported primary endpoints that restricts comparison. 
In addition, there has been limited work on patient- related 
outcome measures suggesting that patients with colorectal 
cancer needs and issues are being overlooked. The Defining 
Standards in Colorectal Optimisation Study aims to achieve 
international consensus from all stakeholders on key standards 
to provide a framework for reporting future prehabilitation 
research.
Methods and analysis A systematic review will identify 
key standards reported in trials of prehabilitation in colorectal 
surgery. Standards that are important to patients will be 
identified by a patient and public involvement (PPI) event. The 
longlist of standards generated from the systematic review 
and PPI event will be used to develop a three- round online 
Delphi process. This will engage all stakeholders (healthcare 
professionals and patients) both nationally and internationally. 
The results of the Delphi will be followed by a face- to- face 
interactive consensus meeting that will define the final 
standards for prehabilitation for elective colorectal surgery.
Ethics and dissemination The University of Glasgow College 
of Medical, Veterinary and Life Sciences Ethics Committee 
has approved this protocol, which is registered as a study 
(200190120) with the Core Outcome Measures in Effectiveness 
Trials Initiative. Publication of the standards developed by 
all stakeholders will increase the potential for comparative 
research that advances understanding of the clinical 
application of prehabilitation.
PROSPERO registration number CRD42019120381.
INTRODUCTION
Elective colorectal surgery for benign and 
malignant conditions is one of the most 
commonly performed operations in the UK.1 
Although mortality is reported as low (3%), 
postoperative morbidity is common varying 
from a minor wound infection to a major 
anastomotic leak that can have significant 
short- term consequences for the patient. After 
discharge, a patient’s recovery can be delayed 
with one in ten requiring emergency readmis-
sion within 30 days.2 To improve patients with 
colorectal cancer outcomes, the development 
of effective strategies is essential.
Enhanced recovery after surgery (ERAS) 
programmes seek to optimise perioperative 
care with the aim of attenuating the stress 
response to surgery.3 The first ERAS protocol 
for colorectal surgery was published in 2005 
and has since been delivered across the UK, 
although with variable components, imple-
mentation and results.4 5 ERAS protocols 
focus on intraoperative and postoperative 
strategies, leaving the preoperative period 
as a potential opportunity for optimisation. 
Prehabilitation, the process of physical, nutri-
tion and psychological optimisation prior to 
surgery, takes advantage of this opportunity 
and has the potential to successfully augment 
ERAS. Demonstrated as safe and feasible 
in predominately patients with colorectal 
cancer,6 early trial evidence and meta- 
analyses7 have reported that prehabilitation 
reduces the number of patients suffering post-
operative complications by 51%,8 as well as 
improving exercise capacity9 and decreasing 
length of hospital stay.10
Strengths and limitations of this study
 ► There is currently no set of standards for prehabilita-
tion research, limiting evidence synthesis.
 ► This study has international and diverse stakehold-
ers, including patients that have been involved since 
study inception.
 ► Limitations of online surveys include selection bias.
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Prehabilitation has gained widespread acceptance 
in recent years with several leading professional bodies 
showing support: Cancer Research UK; the Clinical 
Oncology Society of Australia; American College of Sports 
Medicine (ACSM); International Society of Behavioural 
Nutrition and Physical Activity (ISBNPA); and Macmillan 
Cancer Support. Although prehabilitation is being intro-
duced into clinical practice, there are shortcomings in 
the current evidence base making the next important 
step the definition of standards for the content, delivery 
and measurement of outcomes in prehabilitation inter-
ventions. One major shortcoming is the lack of research 
performed in non- cancer populations, including inflam-
matory bowel disease (IBD), pelvic floor and diverticular 
disease. The situation is made complex by prehabilitation 
research spanning different specialty groups: anaesthetics, 
surgeons, nurse specialists, exercise oncologists/physiolo-
gists, nutritionists and psychologists. Currently, this lack 
of consensus means prehabilitation is varied across the 
UK and beyond, preventing effective comparison and 
compilation of results. Development and implementation 
of standards would encourage homogeneity of data and 
consequently improve the quality of the evidence base to 
enhance patients with colorectal cancer care.
To date, there have been limited efforts to involve 
patients in prehabilitation research. The National Health 
Service (NHS) advocates for patient- centred care,10 
yet often, research is clinician- led and carried out for 
patients, rather than with them.11 In one of the recent 
initiatives by the James Lind Alliance with the National 
Cancer Research Institute (NCRI), over 3500 patients 
with cancer, their caregivers and healthcare and social 
care professionals were asked for their key research 
priorities.12–14 In the final top 10 was ‘what specific life-
style changes help with recovery from cancer treatment, 
restore health, and improve quality of life?’. Prehabilita-
tion research clearly addresses this, and the definition of 
prehabilitation standards will lay important foundations 
to facilitate research to definitively answer this question.
The Defining Standards in Colorectal Optimisation 
(DiSCO) Study intends to achieve consensus on key 
standards for prehabilitation before elective colorectal 
surgery. DiSCO will involve patients and their caregivers 
from the start of the process to ensure that results are 
relevant to service users as well as clinicians. A three- 
stage study design using multidisciplinary stakeholders 
will be followed: systematic review and patient and public 
involvement (PPI) event to develop a standards longlist, 
standards shortlisting using three rounds of online Delphi 
and a face- to- face consensus meeting to define the final 
list of standards for colorectal surgery optimisation.
Aims and objectives
The primary aim of the DiSCO Study is to achieve 
consensus of prehabilitation standards by all stakeholders 
that are to be applied in future trials on prehabilitation in 
elective colorectal surgery.
To achieve this objective, four key questions will be 
asked:
1. What are the individual components of prehabilitation?
2. What type of patient with colorectal cancer should be 
offered prehabilitation?
3. Who should deliver prehabilitation?
4. What outcome measures are important?
METHODS AND ANALYSIS
DiSCO methodology will be guided by the Core Outcome 
Measures in Effectiveness Trials (COMET) Initiative,15 
which provides a handbook instructing the development 
of core outcome sets. However, the scope of this study is 
broader than a core outcome set, also seeking to define 
standards for what prehabilitation should consist of and 
for whom and how it should be delivered. Accordingly, the 
COMET recommendations will be modified to facilitate 
achieving these aims (registered as a study: 200190120).
Patient and public involvement
DiSCO will involve adult patients and their carers/
supporters, who have undergone elective resection of a 
part of their colon or rectum for benign or malignant 
colorectal conditions. These conditions include, but are 
not limited to, colorectal cancer, anal cancer, diverticu-
litis and its complications, IBD and pelvic floor dysfunc-
tion. Patients will be invited through social media to allow 
an international perspective (@DiSCO_study on Twitter 
and Facebook) and by patient liaison groups of profes-
sional bodies and charities, including the Association of 
Coloproctology of Great Britain and Ireland (ACPGBI) 
Patient Liaison Group and The Ileostomy and Internal 
Pouch Support Group.
Stakeholders
From our systematic review and recent work published 
by Macmillan Cancer Support,16 the study group will 
identify key stakeholders that have published on preha-
bilitation. This is likely to include colorectal surgeons, 
colorectal anaesthetists, colorectal nurse specialists, 
colorectal oncologist (medical or clinical), exercise 
oncologists, exercise physiologists, sports scientists, sports 
medicine specialists, physical exercise/activity specialists, 
nutritionists/dieticians, psychologists, geriatricians, phar-
macists and general practitioners. To ensure inclusivity, 
specialist associations related to these stakeholders will 
be approached: ACSM, ISBNPA, Scottish Physical Activity 
Research Collaboration, Macmillan Cancer Support, 
Royal College of Anaesthetists, Association of Surgeons 
of Great Britain and Ireland (ASGBI), ACPGBI, Trainees 
with an Interest in Perioperative Medicine and ERAS 
Association.
Members from each stakeholder group will be 
recruited to form an internationally connected multi-
disciplinary study team. The three cochief investigators 
are an expert patient and two consultant colorectal 
surgeons with research interests in core outcome sets and 
prehabilitation.
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Study design
The DiSCO Study will follow a three- stage process 
(figure 1).
STAGE 1: CREATING STANDARDS LONGLIST
Stage 1 is designed to produce a longlist of standards 
that will be taken forward into Stage 2. This includes a 
systemic review and PPI event. At the end of Stage 1, the 
research team will hold a research meeting to discuss the 
results and ensure clarity on the longlist of standards that 
will be used to create the Delphi Survey.
Systematic review
Research aims to determine the range of interventions 
used in colorectal prehabilitation studies, who delivers 
the interventions, how patients are selected for the inter-
vention (eligibility criteria) and how/what prehabilita-
tion outcomes are measured.
Method: a systematic review of the current prehabilita-
tion literature in patients undergoing colorectal surgery 
has been published.17.
PPI event
Research question: what do patients and their family 
members think is important in a prehabilitation inter-
vention? Specifically: what are the individual components 
of prehabilitation? What type of patient with colorectal 
cancer should be offered prehabilitation? Who should 
deliver prehabilitation? What outcome measures are 
important, and how should they be measured?
Method
Inclusion criteria:
 ► Adults over 18 years of age.
 ► Patients who have completed or have planned 
colorectal surgery.
 ► Underlying indication for surgery could be for benign 
or malignant pathology.
 ► Able to understand, interpret and communicate in 
English.
Exclusion criteria:
 ► Acute or chronic issues with memory and/or cognition
Sampling
The patient information sheet (PIS) will be sent to 
colleagues from one hospital department that includes 
nurses, colorectal nurse specialists (cancer, inflammatory 
disease, stoma therapists and ERAS specialists), allied 
health professionals and surgeons. Proposed partici-
pants will then be sent the PIS and asked to confirm 
their attendance by telephone. All patients will be 
invited to bring family members and/or caregivers to the 
event. The second strategy to identify patients will be to 
approach representatives from local community groups 
that encourage lifestyle change in patients. Appropriate 
patients will then be discussed with the research team, 
and the PIS will be sent out accordingly. A target of 20 
participants will be sought, with a minimum of 10 of these 
being patients.
Event location
The PPI event will be held over 4–5 hours at the hospital 
of one of the surgeons, in a designated quiet and easily 
accessible room with the capacity to hold 20–30 people 
comfortably. Participants will be reimbursed for travel 
expenses. If the event occurs during the COVID-19 
pandemic, then the format will be moved to a secure 
online NHS- approved virtual platform.
Event format
The event will be led by the research team that includes 
expert patient and colorectal surgeons. The event will 
be facilitated by colorectal nurse specialist, enhanced 
recovery nurse specialist, medical students, anaesthetists 
and surgical/oncological research fellows.
A PowerPoint presentation will be used to give structure 
to the event. It will include introductions, definitions and 
explanation of prehabilitation and the aims of the DiSCO 
Study. Patients will be invited to share their experiences 
of colorectal surgery and any preparation or prehabilita-
tion they underwent beforehand. To explore the four key 
aims of the DiSCO Study, the patients will be divided into 
small groups each facilitated by members of the research 
team. The whole group will then reconvene for an inter-
active and patient- led discussion to develop their answers 
to the four study questions.
Analysis
Comprehensive field notes will be taken by the research 
team. Thematic analysis will organise the patients’ views 
into themes that will be incorporated into the longlisting. 
All patients and family members in attendance will be 
invited to leave their email address to be contacted for 
inclusion in Stage 2.
Figure 1 Diagram of study design.
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STAGE 2: CREATING STANDARDS SHORTLIST
A three- round online modified Delphi process will be 
performed to develop a shortlist.18 Adhering to recom-
mendations by COMET,15 standards will be split into four 
domains reflecting the key study questions: content of 
prehabilitation, recipients of prehabilitation, delivery 
of prehabilitation and the measurement/assessment of 
prehabilitation. Participants will be asked to rank the 
importance of each standard on a validated 9- point Likert 
scale, which is recommended by the Grading of Recom-
mendations, Assessment, Development and Evaluation 
working group.19 With this scale, a score of 1–3 signifies 
that the standard is of little importance, 4–6 some impor-
tance and 7–9 critical importance. Round 1 will ask partic-
ipants to rank every item of the longlist, and differences 
in rankings between stakeholder groups will be explored. 
To reduce bias, a predetermined consensus threshold will 
be used: Standards that are ranked of critical importance 
(7–9) by >70% or of little importance (1–3) by <15% of 
each stakeholder group will be deemed to have reached 
the threshold for consensus for inclusion in the shortlist 
of key standards. After round 1 of the Delphi, standards 
reaching the threshold of consensus for inclusion will be 
directly added to the shortlist and not included in subse-
quent rounds. All items not reaching this threshold will 
be taken forward to round 2. The same criteria will be 
used after round 2 to select items to take forward into 
round 3. After round 3, any additional items reaching 
the threshold for consensus for inclusion will be added to 
the shortlist. Any items that are ranked of critical impor-
tance (7–9) by <50% of each stakeholder group or of little 
importance (1–3) by >50% of each stakeholder group 
after round 3 will be excluded from the final shortlist. 
Standards that do not meet the criteria for inclusion or 
exclusion will be considered borderline. The final short-
list and borderline items will be taken forward for discus-
sion at the final consensus meeting.
The online survey will be powered by COMET Delphi-
Manager software. Representatives from each of the 
key stakeholder groups will be invited to participate to 
ensure adequate representation. A target of 100 or more 
respondents will be sought. Multiple methods will be 
used for recruitment to maximise the sample size and 
participant diversity. Study group members who have 
membership with professional societies will be there for 
recruitment, including ACPGBI, ACPGBI Patient Liaison 
Group, ASGBI, ISBNPA and NCRI. Social media networks 
(Twitter and Facebook) will also be used to advertise the 
study, hopefully engaging patients with colorectal cancer 
and members of the public. Patients without access to 
social media will be targeted through the patient support 
charities. Participants from the PPI event who left their 
email addresses will also receive an invitation to partake 
in the Delphi Study.
STAGE 3: FINALISING STANDARDS SET
The shortlist from the Delphi process will be reviewed 
at a meeting of stakeholder representatives to agree on 
a final set of standards for publishing, as recommended 
by the COMET Initiative.15 The meeting is planned to 
be held face- to- face, but this will depend on COVID-19 
restrictions. If a face- to- face meeting is not possible, 
then it will be held online using videoconferencing soft-
ware. A random sample of around 50 stakeholders will 
be invited using contacts from the PPI event and Delphi 
Survey participants who gave permission to be contacted 
about the stakeholder event. The shortlist of standards 
that met the threshold for consensus after each round 
of the Delphi will be presented and ratified by vote. 
The borderline standards will be discussed and voted 
on individually. For each standard, the group will anon-
ymously rank its importance on the same 9- point scale 
used in the Delphi Study to establish a group baseline. 
Following this, there will be a group discussion of the 
standard with arguments for and against its inclusion in 
the final standards set. A further round of anonymous 
voting will follow. A result of at least 70% ranking the 
standard as critically important and fewer than 15% 
ranking it of little importance will be required for inclu-
sion in the final standards set. There are no universally 
agreed consensus criteria, and the criteria used here 
follow published recommendations.20
Ethics and dissemination
This work that includes a wide range of stakeholders, 
including patients, is performed with robust method-
ology ensuring that the results accurately reflect the 
priorities of all stakeholder groups and will be reported 
using Guidance on Conducting and REporting DElphi 
Studies.21 Publication in peer- reviewed journals and 
dissemination through the professional collaborations 
and associated networks should ensure international 
adoption of the standards. Such adoption will help to 
standardise future prehabilitation study design and 
reporting to optimise the progression of prehabilitation 
for researchers, clinicians and patients. The University of 
Glasgow College of Medical, Veterinary and Life Sciences 
Ethics Committee approved the protocol on 7 July 2020 
(200190120).
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